AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 10 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2024. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,291,106 | +12.1% | 76,442 | -6.2% | 0.00% | – |
| Q4 2023 | $1,151,232 | +42.4% | 81,532 | +3.9% | 0.00% | – |
| Q3 2023 | $808,395 | -8.1% | 78,485 | +47.0% | 0.00% | – |
| Q2 2023 | $879,768 | +103.5% | 53,384 | +13.1% | 0.00% | – |
| Q1 2023 | $432,343 | +57.6% | 47,199 | +23.2% | 0.00% | – |
| Q4 2022 | $274,357 | +60.4% | 38,318 | +12.5% | 0.00% | – |
| Q3 2022 | $171,000 | +144.3% | 34,069 | +18.4% | 0.00% | – |
| Q2 2022 | $70,000 | -72.1% | 28,770 | -21.6% | 0.00% | – |
| Q1 2022 | $251,000 | +3.7% | 36,706 | +22.7% | 0.00% | – |
| Q4 2021 | $242,000 | -17.4% | 29,924 | +0.0% | 0.00% | – |
| Q3 2021 | $293,000 | +77.6% | 29,915 | +21.7% | 0.00% | – |
| Q2 2021 | $165,000 | -96.4% | 24,578 | -95.2% | 0.00% | – |
| Q1 2021 | $4,604,000 | +18.1% | 509,284 | -12.7% | 0.00% | – |
| Q4 2020 | $3,898,000 | +83.7% | 583,668 | +20.7% | 0.00% | – |
| Q3 2018 | $2,122,000 | -29.1% | 483,369 | -1.0% | 0.00% | – |
| Q2 2018 | $2,992,000 | -19.9% | 488,138 | -4.7% | 0.00% | – |
| Q1 2018 | $3,735,000 | -19.0% | 512,451 | -8.9% | 0.00% | – |
| Q4 2017 | $4,611,000 | -24.7% | 562,339 | -3.6% | 0.00% | – |
| Q3 2017 | $6,124,000 | +5.6% | 583,254 | +10.9% | 0.00% | – |
| Q2 2017 | $5,799,000 | +10.2% | 525,738 | -3.3% | 0.00% | – |
| Q1 2017 | $5,263,000 | – | 543,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,416,326 | $34,118,517 | 12.83% |
| Knoll Capital Management, LLC | 600,000 | $8,472,000 | 7.02% |
| Tri Locum Partners LP | 839,933 | $11,859,854 | 5.42% |
| Vivo Capital, LLC | 4,096,428 | $57,841,563 | 4.74% |
| GENDELL JEFFREY L | 5,615,350 | $79,288,742 | 4.31% |
| Ally Bridge Group (NY) LLC | 347,036 | $4,900,148 | 2.92% |
| Checkpoint Capital L.P. | 325,000 | $4,589,000 | 2.78% |
| MPM BioImpact LLC | 664,986 | $9,389,602 | 2.20% |
| Samsara BioCapital, LLC | 967,527 | $13,661,481 | 2.12% |
| RTW INVESTMENTS, LP | 6,947,918 | $98,104,602 | 1.53% |